ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

ClinicalTrials.gov ID: NCT00369785

Public ClinicalTrials.gov record NCT00369785. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain

Study identification

NCT ID
NCT00369785
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Wake Forest University Health Sciences
Other
Enrollment
198 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • donepezil hydrochloride Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Jun 30, 2012
Completion
Jun 30, 2012
Last update posted
Oct 19, 2021

2008 – 2012

United States locations

U.S. sites
16
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
Associates in Womens Health, PA - North Review Wichita Kansas 67208
Cancer Center of Kansas, PA - Medical Arts Tower Wichita Kansas 67208
Cancer Center of Kansas, PA - Wichita Wichita Kansas 67214
CCOP - Wichita Wichita Kansas 67214
Via Christi Cancer Center at Via Christi Regional Medical Center Wichita Kansas 67214
Central Maine Comprehensive Cancer Center at Central Maine Medical Center Lewiston Maine 04240
New Hampshire Oncology - Hematology, PA - Hooksett Hooksett New Hampshire 03106
Lakes Region General Hospital Laconia New Hampshire 03246
Don Monti Comprehensive Cancer Center at North Shore University Hospital Manhasset New York 11030
CCOP - MeritCare Hospital Fargo North Dakota 58122
Trinity CancerCare Center Minot North Dakota 58701
Summa Center for Cancer Care at Akron City Hospital Akron Ohio 44309-2090
MetroHealth Cancer Care Center at MetroHealth Medical Center Cleveland Ohio 44109
United States Air Force Medical Center - Wright-Patterson Wright-Patterson Air Force Base Ohio 45433-5529
Thompson Cancer Survival Center Knoxville Tennessee 37916
Gundersen Lutheran Center for Cancer and Blood La Crosse Wisconsin 54601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00369785, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2021 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00369785 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →